Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Interim phase I data on E-7080 in hepatocellular carcinoma disclosed at ILCA meeting

Sep. 8, 2011

Boehringer Ingelheim provides updates on two phase II afatinib trials in breast cancer

Sep. 7, 2011

Merck KGaA presents novel TGFR-1 inhibitors

Sep. 7, 2011

EVOLVE-1 trial assesses mTOR inhibitor plus best supportive care in hepatocellular carcinoma

Sep. 7, 2011

Randomized phase II trial to evaluate LY-2523355 in metastatic breast cancer

Sep. 6, 2011

FDA issues warning regarding 5-alpha reductase inhibitors

Sep. 6, 2011

Promising results reported from phase II SAPHIRE trial

Sep. 6, 2011

NCI recruits patients for phase II trial of sipuleucel-T

Sep. 6, 2011

OXiGENE restructures clinical programs for Zybrestat and OXI-4503

Sep. 5, 2011

Trastuzumab enters phase II trial in Paget's disease

Sep. 5, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...